Inhibitex, Inc. (INHX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-18.01M
Depreciation and amortization	471.71K
Share-based compensation	997.23K
Amortization of investment premium or discount	372.15K
Prepaid expenses and other assets	-807.52K
Accounts receivable	73.25K
Accounts payable and other liabilities	-277.62K
Accrued expenses	-380.04K
Deferred revenue	-87.5K
Net cash used in operating activities	-17.64M
Purchases of property and equipment	-69.42K
Purchases of investments	-55M
Proceeds from maturities of investments	27.91M
Net cash provided by (used in) investing activities	-27.16M
Payments on promissory notes and capital leases	-340.97K
Proceeds from the exercise of stock options and warrants	2.02M
Proceeds from the issuance of common stock	50.81M
Public offering expenses	-247.47K
Net cash provided by financing activities	52.24M
Increase (decrease) in cash and cash equivalents	7.43M
Cash and cash equivalents at beginning of period	8.55M
Cash and cash equivalents at end of period	15.99M
Interest paid	14.3K
Issuance of common stock from cashless warrant exercise	173.02K

Entities mentioned with INHX

View All Entities